Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02797574 · ClinicalTrials.gov registry record · NA
Stress Response Pathways in Vitiligo
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02797574: Completed NA study, sponsored by NYU Langone Health.
NCT02797574 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02797574, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate stress response pathways in tissues and melanocytes from patients with vitiligo. Investigators are collecting evidence of UPR and stress response activation in tissues and melanocytes from patients with vitiligo. Individuals with vitiligo will have punch biopsies to study stress response UPR activation and NF-κB signaling to test our hypothesis. In order to characterize differences between disease and normal states, a second arm of control individuals (Arm 2) will be recruited.
Interventions
- PROCEDURE Punch Biopsy at a Lesional Site
- PROCEDURE Punch Biopsy at a Non- Lesional site
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2015-10 |
| Est. Completion | 2021-09-22 |
| Phase | NA |
What the finished NCT02797574 record still lists
NCT02797574 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Punch Biopsy at a Lesional Site is the first listed.
NCT02797574 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02797574 about?
NCT02797574 is a clinical study titled "Stress Response Pathways in Vitiligo". The purpose of this study is to investigate stress response pathways in tissues and melanocytes from patients with vitiligo. Investigators are collecting evidence of UPR and stress response activation in tissues and melanocytes from patients with vitiligo. Individuals with vitiligo will have punch b...
What is the current status of trial NCT02797574?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2015-10. Estimated completion is 2021-09-22.
What interventions are being tested in trial NCT02797574?
The interventions under investigation include: Punch Biopsy at a Lesional Site (PROCEDURE), Punch Biopsy at a Non- Lesional site (PROCEDURE).
Who is sponsoring clinical trial NCT02797574?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02797574's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia